Bliss Group names Cortney Stapleton CEO

Published on 1st March 2023

Our partner, The Bliss Group based in New York, U.S.  has promoted Cortney Stapleton to CEO. She will prepare the firm for a sustainable growth path led by new practice development and the integration of data science and analytics throughout its entire offering. The agency also launched Bliss Bio, a healthcare initiative, last year, with plans to continue a focus on professional services, financial services, healthcare and tech in partnerships with clients this year.

Read more on: Bliss Group names Cortney Stapleton CEO

Related Insights

15 Jul 2026

The Ball Algorithm: How Screens Create the Market’s New Idols

The real paradigm shift in sports lies in how people discovered they…

Read more

11 Jul 2026

The Conversation Pharma Isn't Controlling — and What to Do About It

There is a fundamental mismatch between what pharmaceutical companies say and what…

Read more

10 Jul 2026

Built to Trust or Built to Fail? The Real State of Pharma Corporate Websites

A pharmaceutical company’s corporate website is more than a digital presence. It…

Read more